Click for best price
Therapeutic Radiopharmaceuticals Market Size, Share 2022
Market Analysis and Insights: Global Therapeutic Radiopharmaceuticals Market
The global Therapeutic Radiopharmaceuticals market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Therapeutic Radiopharmaceuticals market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Therapeutic Radiopharmaceuticals market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Therapeutic Radiopharmaceuticals market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Therapeutic Radiopharmaceuticals market.
Global Therapeutic Radiopharmaceuticals Scope and Market Size
Therapeutic Radiopharmaceuticals market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Therapeutic Radiopharmaceuticals market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Radium-223
Lutetium-177
Iodine-131
Other
Segment by Application
Thyroid
Bone Metastasis
Lymphoma
Other
By Company
Bayer
Novartis
China Isotope & Radiation
Dongcheng
Q BioMed
Curium Pharmaceuticals
Jubilant DraxImage
Lantheus
Spectrum Pharmaceuticals
Progenics Pharmaceuticals
International Isotopes
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
The information for each competitor/Company Profile includes:
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
The content of the study subjects includes a total of 15 chapters:
Chapter 1, describes Therapeutic Radiopharmaceuticals product scope, market overview, market opportunities, market driving force, and market risks.
Chapter 2, profiles the top manufacturers of Therapeutic Radiopharmaceuticals, with price, sales, revenue, and global market share of Therapeutic Radiopharmaceuticals from 2019 to 2022.
Chapter 3, the Therapeutic Radiopharmaceuticals competitive situation, sales, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Therapeutic Radiopharmaceuticals breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapters 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, and application, from 2017 to 2028.
Chapters 7, 8, 9, 10, and 11, to break the sales data at the country level, with sales, revenue, and market share for key countries in the world, from 2017 to 2022. and the Therapeutic Radiopharmaceuticals market forecast, by regions, type, and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Therapeutic Radiopharmaceuticals.
Chapter 13, 14, and 15, to describe Therapeutic Radiopharmaceuticals sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Key Indicators Analysed:
- Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market?s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
- Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
- Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
- Opportunities and Drivers: Identifying the Growing Demands and New Technology
- Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.
Reasons to Purchase this Report:
- Estimates 2022-2027 2021-2025 Therapeutic Radiopharmaceuticals Report on, Status and Forecast, by Players, Types and Applications market development trends with the recent trends and SWOT analysis
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
- Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
- Market value (USD Million) and volume (Units Million) data for each segment and sub-segment
- Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
- Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
- 1-year analyst support, along with the data support in excel format.
Research Methodology:
The research methodology used to estimate and forecast this market begins by capturing the revenues of the key players and their shares in the market. Various secondary sources such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, have been used to identify and collect information useful for this extensive commercial study of the market. Calculations based on this led to the overall market size. After arriving at the overall market size, the total market has been split into several segments and subsegments, which have then been verified through primary research by conducting extensive interviews with industry experts such as CEOs, VPs, directors, and executives. The data triangulation and market breakdown procedures have been employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments.
| Report Attributes |
Report Details |
| Report Title |
Global Therapeutic Radiopharmaceuticals Market Insights, Forecast to 2028 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2021 |
| Forecast Year |
2029 |
| Number of Pages |
105 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Study Coverage
1.1 Therapeutic Radiopharmaceuticals Product Introduction
1.2 Market by Type
1.2.1 Global Therapeutic Radiopharmaceuticals Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Radium-223
1.2.3 Lutetium-177
1.2.4 Iodine-131
1.2.5 Other
1.3 Market by Application
1.3.1 Global Therapeutic Radiopharmaceuticals Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Thyroid
1.3.3 Bone Metastasis
1.3.4 Lymphoma
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Therapeutic Radiopharmaceuticals Sales Estimates and Forecasts 2017-2028
2.2 Global Therapeutic Radiopharmaceuticals Revenue Estimates and Forecasts 2017-2028
2.3 Global Therapeutic Radiopharmaceuticals Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Therapeutic Radiopharmaceuticals Sales by Region
2.4.1 Global Therapeutic Radiopharmaceuticals Sales by Region (2017-2022)
2.4.2 Global Sales Therapeutic Radiopharmaceuticals by Region (2023-2028)
2.5 Global Therapeutic Radiopharmaceuticals Revenue by Region
2.5.1 Global Therapeutic Radiopharmaceuticals Revenue by Region (2017-2022)
2.5.2 Global Therapeutic Radiopharmaceuticals Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Therapeutic Radiopharmaceuticals Sales by Manufacturers
3.1.1 Global Top Therapeutic Radiopharmaceuticals Manufacturers by Sales (2017-2022)
3.1.2 Global Therapeutic Radiopharmaceuticals Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Therapeutic Radiopharmaceuticals in 2021
3.2 Global Therapeutic Radiopharmaceuticals Revenue by Manufacturers
3.2.1 Global Therapeutic Radiopharmaceuticals Revenue by Manufacturers (2017-2022)
3.2.2 Global Therapeutic Radiopharmaceuticals Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Therapeutic Radiopharmaceuticals Revenue in 2021
3.3 Global Therapeutic Radiopharmaceuticals Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Therapeutic Radiopharmaceuticals Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Therapeutic Radiopharmaceuticals Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Therapeutic Radiopharmaceuticals Sales by Type
4.1.1 Global Therapeutic Radiopharmaceuticals Historical Sales by Type (2017-2022)
4.1.2 Global Therapeutic Radiopharmaceuticals Forecasted Sales by Type (2023-2028)
4.1.3 Global Therapeutic Radiopharmaceuticals Sales Market Share by Type (2017-2028)
4.2 Global Therapeutic Radiopharmaceuticals Revenue by Type
4.2.1 Global Therapeutic Radiopharmaceuticals Historical Revenue by Type (2017-2022)
4.2.2 Global Therapeutic Radiopharmaceuticals Forecasted Revenue by Type (2023-2028)
4.2.3 Global Therapeutic Radiopharmaceuticals Revenue Market Share by Type (2017-2028)
4.3 Global Therapeutic Radiopharmaceuticals Price by Type
4.3.1 Global Therapeutic Radiopharmaceuticals Price by Type (2017-2022)
4.3.2 Global Therapeutic Radiopharmaceuticals Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Therapeutic Radiopharmaceuticals Sales by Application
5.1.1 Global Therapeutic Radiopharmaceuticals Historical Sales by Application (2017-2022)
5.1.2 Global Therapeutic Radiopharmaceuticals Forecasted Sales by Application (2023-2028)
5.1.3 Global Therapeutic Radiopharmaceuticals Sales Market Share by Application (2017-2028)
5.2 Global Therapeutic Radiopharmaceuticals Revenue by Application
5.2.1 Global Therapeutic Radiopharmaceuticals Historical Revenue by Application (2017-2022)
5.2.2 Global Therapeutic Radiopharmaceuticals Forecasted Revenue by Application (2023-2028)
5.2.3 Global Therapeutic Radiopharmaceuticals Revenue Market Share by Application (2017-2028)
5.3 Global Therapeutic Radiopharmaceuticals Price by Application
5.3.1 Global Therapeutic Radiopharmaceuticals Price by Application (2017-2022)
5.3.2 Global Therapeutic Radiopharmaceuticals Price Forecast by Application (2023-2028)
6 North America
6.1 North America Therapeutic Radiopharmaceuticals Market Size by Type
6.1.1 North America Therapeutic Radiopharmaceuticals Sales by Type (2017-2028)
6.1.2 North America Therapeutic Radiopharmaceuticals Revenue by Type (2017-2028)
6.2 North America Therapeutic Radiopharmaceuticals Market Size by Application
6.2.1 North America Therapeutic Radiopharmaceuticals Sales by Application (2017-2028)
6.2.2 North America Therapeutic Radiopharmaceuticals Revenue by Application (2017-2028)
6.3 North America Therapeutic Radiopharmaceuticals Market Size by Country
6.3.1 North America Therapeutic Radiopharmaceuticals Sales by Country (2017-2028)
6.3.2 North America Therapeutic Radiopharmaceuticals Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Therapeutic Radiopharmaceuticals Market Size by Type
7.1.1 Europe Therapeutic Radiopharmaceuticals Sales by Type (2017-2028)
7.1.2 Europe Therapeutic Radiopharmaceuticals Revenue by Type (2017-2028)
7.2 Europe Therapeutic Radiopharmaceuticals Market Size by Application
7.2.1 Europe Therapeutic Radiopharmaceuticals Sales by Application (2017-2028)
7.2.2 Europe Therapeutic Radiopharmaceuticals Revenue by Application (2017-2028)
7.3 Europe Therapeutic Radiopharmaceuticals Market Size by Country
7.3.1 Europe Therapeutic Radiopharmaceuticals Sales by Country (2017-2028)
7.3.2 Europe Therapeutic Radiopharmaceuticals Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Therapeutic Radiopharmaceuticals Market Size by Type
8.1.1 Asia Pacific Therapeutic Radiopharmaceuticals Sales by Type (2017-2028)
8.1.2 Asia Pacific Therapeutic Radiopharmaceuticals Revenue by Type (2017-2028)
8.2 Asia Pacific Therapeutic Radiopharmaceuticals Market Size by Application
8.2.1 Asia Pacific Therapeutic Radiopharmaceuticals Sales by Application (2017-2028)
8.2.2 Asia Pacific Therapeutic Radiopharmaceuticals Revenue by Application (2017-2028)
8.3 Asia Pacific Therapeutic Radiopharmaceuticals Market Size by Region
8.3.1 Asia Pacific Therapeutic Radiopharmaceuticals Sales by Region (2017-2028)
8.3.2 Asia Pacific Therapeutic Radiopharmaceuticals Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Therapeutic Radiopharmaceuticals Market Size by Type
9.1.1 Latin America Therapeutic Radiopharmaceuticals Sales by Type (2017-2028)
9.1.2 Latin America Therapeutic Radiopharmaceuticals Revenue by Type (2017-2028)
9.2 Latin America Therapeutic Radiopharmaceuticals Market Size by Application
9.2.1 Latin America Therapeutic Radiopharmaceuticals Sales by Application (2017-2028)
9.2.2 Latin America Therapeutic Radiopharmaceuticals Revenue by Application (2017-2028)
9.3 Latin America Therapeutic Radiopharmaceuticals Market Size by Country
9.3.1 Latin America Therapeutic Radiopharmaceuticals Sales by Country (2017-2028)
9.3.2 Latin America Therapeutic Radiopharmaceuticals Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Therapeutic Radiopharmaceuticals Market Size by Type
10.1.1 Middle East and Africa Therapeutic Radiopharmaceuticals Sales by Type (2017-2028)
10.1.2 Middle East and Africa Therapeutic Radiopharmaceuticals Revenue by Type (2017-2028)
10.2 Middle East and Africa Therapeutic Radiopharmaceuticals Market Size by Application
10.2.1 Middle East and Africa Therapeutic Radiopharmaceuticals Sales by Application (2017-2028)
10.2.2 Middle East and Africa Therapeutic Radiopharmaceuticals Revenue by Application (2017-2028)
10.3 Middle East and Africa Therapeutic Radiopharmaceuticals Market Size by Country
10.3.1 Middle East and Africa Therapeutic Radiopharmaceuticals Sales by Country (2017-2028)
10.3.2 Middle East and Africa Therapeutic Radiopharmaceuticals Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Bayer
11.1.1 Bayer Corporation Information
11.1.2 Bayer Overview
11.1.3 Bayer Therapeutic Radiopharmaceuticals Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Bayer Therapeutic Radiopharmaceuticals Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Bayer Recent Developments
11.2 Novartis
11.2.1 Novartis Corporation Information
11.2.2 Novartis Overview
11.2.3 Novartis Therapeutic Radiopharmaceuticals Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Novartis Therapeutic Radiopharmaceuticals Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Novartis Recent Developments
11.3 China Isotope & Radiation
11.3.1 China Isotope & Radiation Corporation Information
11.3.2 China Isotope & Radiation Overview
11.3.3 China Isotope & Radiation Therapeutic Radiopharmaceuticals Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 China Isotope & Radiation Therapeutic Radiopharmaceuticals Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 China Isotope & Radiation Recent Developments
11.4 Dongcheng
11.4.1 Dongcheng Corporation Information
11.4.2 Dongcheng Overview
11.4.3 Dongcheng Therapeutic Radiopharmaceuticals Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Dongcheng Therapeutic Radiopharmaceuticals Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Dongcheng Recent Developments
11.5 Q BioMed
11.5.1 Q BioMed Corporation Information
11.5.2 Q BioMed Overview
11.5.3 Q BioMed Therapeutic Radiopharmaceuticals Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Q BioMed Therapeutic Radiopharmaceuticals Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Q BioMed Recent Developments
11.6 Curium Pharmaceuticals
11.6.1 Curium Pharmaceuticals Corporation Information
11.6.2 Curium Pharmaceuticals Overview
11.6.3 Curium Pharmaceuticals Therapeutic Radiopharmaceuticals Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Curium Pharmaceuticals Therapeutic Radiopharmaceuticals Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Curium Pharmaceuticals Recent Developments
11.7 Jubilant DraxImage
11.7.1 Jubilant DraxImage Corporation Information
11.7.2 Jubilant DraxImage Overview
11.7.3 Jubilant DraxImage Therapeutic Radiopharmaceuticals Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Jubilant DraxImage Therapeutic Radiopharmaceuticals Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Jubilant DraxImage Recent Developments
11.8 Lantheus
11.8.1 Lantheus Corporation Information
11.8.2 Lantheus Overview
11.8.3 Lantheus Therapeutic Radiopharmaceuticals Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Lantheus Therapeutic Radiopharmaceuticals Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Lantheus Recent Developments
11.9 Spectrum Pharmaceuticals
11.9.1 Spectrum Pharmaceuticals Corporation Information
11.9.2 Spectrum Pharmaceuticals Overview
11.9.3 Spectrum Pharmaceuticals Therapeutic Radiopharmaceuticals Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Spectrum Pharmaceuticals Therapeutic Radiopharmaceuticals Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Spectrum Pharmaceuticals Recent Developments
11.10 Progenics Pharmaceuticals
11.10.1 Progenics Pharmaceuticals Corporation Information
11.10.2 Progenics Pharmaceuticals Overview
11.10.3 Progenics Pharmaceuticals Therapeutic Radiopharmaceuticals Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Progenics Pharmaceuticals Therapeutic Radiopharmaceuticals Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Progenics Pharmaceuticals Recent Developments
11.11 International Isotopes
11.11.1 International Isotopes Corporation Information
11.11.2 International Isotopes Overview
11.11.3 International Isotopes Therapeutic Radiopharmaceuticals Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 International Isotopes Therapeutic Radiopharmaceuticals Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 International Isotopes Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Therapeutic Radiopharmaceuticals Industry Chain Analysis
12.2 Therapeutic Radiopharmaceuticals Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Therapeutic Radiopharmaceuticals Production Mode & Process
12.4 Therapeutic Radiopharmaceuticals Sales and Marketing
12.4.1 Therapeutic Radiopharmaceuticals Sales Channels
12.4.2 Therapeutic Radiopharmaceuticals Distributors
12.5 Therapeutic Radiopharmaceuticals Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Therapeutic Radiopharmaceuticals Industry Trends
13.2 Therapeutic Radiopharmaceuticals Market Drivers
13.3 Therapeutic Radiopharmaceuticals Market Challenges
13.4 Therapeutic Radiopharmaceuticals Market Restraints
14 Key Findings in The Global Therapeutic Radiopharmaceuticals Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Global Therapeutic Radiopharmaceuticals Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Radium-223
Table 3. Major Manufacturers of Lutetium-177
Table 4. Major Manufacturers of Iodine-131
Table 5. Major Manufacturers of Other
Table 6. Global Therapeutic Radiopharmaceuticals Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 7. Global Therapeutic Radiopharmaceuticals Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 8. Global Therapeutic Radiopharmaceuticals Sales by Region (2017-2022) & (K Units)
Table 9. Global Therapeutic Radiopharmaceuticals Sales Market Share by Region (2017-2022)
Table 10. Global Therapeutic Radiopharmaceuticals Sales by Region (2023-2028) & (K Units)
Table 11. Global Therapeutic Radiopharmaceuticals Sales Market Share by Region (2023-2028)
Table 12. Global Therapeutic Radiopharmaceuticals Revenue by Region (2017-2022) & (US$ Million)
Table 13. Global Therapeutic Radiopharmaceuticals Revenue Market Share by Region (2017-2022)
Table 14. Global Therapeutic Radiopharmaceuticals Revenue by Region (2023-2028) & (US$ Million)
Table 15. Global Therapeutic Radiopharmaceuticals Revenue Market Share by Region (2023-2028)
Table 16. Global Therapeutic Radiopharmaceuticals Sales by Manufacturers (2017-2022) & (K Units)
Table 17. Global Therapeutic Radiopharmaceuticals Sales Share by Manufacturers (2017-2022)
Table 18. Global Therapeutic Radiopharmaceuticals Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 19. Global Therapeutic Radiopharmaceuticals Revenue Share by Manufacturers (2017-2022)
Table 20. Therapeutic Radiopharmaceuticals Price by Manufacturers (2017-2022) &(USD/Unit)
Table 21. Global Therapeutic Radiopharmaceuticals Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Therapeutic Radiopharmaceuticals by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Therapeutic Radiopharmaceuticals as of 2021)
Table 23. Therapeutic Radiopharmaceuticals Manufacturing Base Distribution and Headquarters
Table 24. Manufacturers Therapeutic Radiopharmaceuticals Product Offered
Table 25. Date of Manufacturers Enter into Therapeutic Radiopharmaceuticals Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Therapeutic Radiopharmaceuticals Sales by Type (2017-2022) & (K Units)
Table 28. Global Therapeutic Radiopharmaceuticals Sales by Type (2023-2028) & (K Units)
Table 29. Global Therapeutic Radiopharmaceuticals Sales Share by Type (2017-2022)
Table 30. Global Therapeutic Radiopharmaceuticals Sales Share by Type (2023-2028)
Table 31. Global Therapeutic Radiopharmaceuticals Revenue by Type (2017-2022) & (US$ Million)
Table 32. Global Therapeutic Radiopharmaceuticals Revenue by Type (2023-2028) & (US$ Million)
Table 33. Global Therapeutic Radiopharmaceuticals Revenue Share by Type (2017-2022)
Table 34. Global Therapeutic Radiopharmaceuticals Revenue Share by Type (2023-2028)
Table 35. Therapeutic Radiopharmaceuticals Price by Type (2017-2022) & (USD/Unit)
Table 36. Global Therapeutic Radiopharmaceuticals Price Forecast by Type (2023-2028) & (USD/Unit)
Table 37. Global Therapeutic Radiopharmaceuticals Sales by Application (2017-2022) & (K Units)
Table 38. Global Therapeutic Radiopharmaceuticals Sales by Application (2023-2028) & (K Units)
Table 39. Global Therapeutic Radiopharmaceuticals Sales Share by Application (2017-2022)
Table 40. Global Therapeutic Radiopharmaceuticals Sales Share by Application (2023-2028)
Table 41. Global Therapeutic Radiopharmaceuticals Revenue by Application (2017-2022) & (US$ Million)
Table 42. Global Therapeutic Radiopharmaceuticals Revenue by Application (2023-2028) & (US$ Million)
Table 43. Global Therapeutic Radiopharmaceuticals Revenue Share by Application (2017-2022)
Table 44. Global Therapeutic Radiopharmaceuticals Revenue Share by Application (2023-2028)
Table 45. Therapeutic Radiopharmaceuticals Price by Application (2017-2022) & (USD/Unit)
Table 46. Global Therapeutic Radiopharmaceuticals Price Forecast by Application (2023-2028) & (USD/Unit)
Table 47. North America Therapeutic Radiopharmaceuticals Sales by Type (2017-2022) & (K Units)
Table 48. North America Therapeutic Radiopharmaceuticals Sales by Type (2023-2028) & (K Units)
Table 49. North America Therapeutic Radiopharmaceuticals Revenue by Type (2017-2022) & (US$ Million)
Table 50. North America Therapeutic Radiopharmaceuticals Revenue by Type (2023-2028) & (US$ Million)
Table 51. North America Therapeutic Radiopharmaceuticals Sales by Application (2017-2022) & (K Units)
Table 52. North America Therapeutic Radiopharmaceuticals Sales by Application (2023-2028) & (K Units)
Table 53. North America Therapeutic Radiopharmaceuticals Revenue by Application (2017-2022) & (US$ Million)
Table 54. North America Therapeutic Radiopharmaceuticals Revenue by Application (2023-2028) & (US$ Million)
Table 55. North America Therapeutic Radiopharmaceuticals Sales by Country (2017-2022) & (K Units)
Table 56. North America Therapeutic Radiopharmaceuticals Sales by Country (2023-2028) & (K Units)
Table 57. North America Therapeutic Radiopharmaceuticals Revenue by Country (2017-2022) & (US$ Million)
Table 58. North America Therapeutic Radiopharmaceuticals Revenue by Country (2023-2028) & (US$ Million)
Table 59. Europe Therapeutic Radiopharmaceuticals Sales by Type (2017-2022) & (K Units)
Table 60. Europe Therapeutic Radiopharmaceuticals Sales by Type (2023-2028) & (K Units)
Table 61. Europe Therapeutic Radiopharmaceuticals Revenue by Type (2017-2022) & (US$ Million)
Table 62. Europe Therapeutic Radiopharmaceuticals Revenue by Type (2023-2028) & (US$ Million)
Table 63. Europe Therapeutic Radiopharmaceuticals Sales by Application (2017-2022) & (K Units)
Table 64. Europe Therapeutic Radiopharmaceuticals Sales by Application (2023-2028) & (K Units)
Table 65. Europe Therapeutic Radiopharmaceuticals Revenue by Application (2017-2022) & (US$ Million)
Table 66. Europe Therapeutic Radiopharmaceuticals Revenue by Application (2023-2028) & (US$ Million)
Table 67. Europe Therapeutic Radiopharmaceuticals Sales by Country (2017-2022) & (K Units)
Table 68. Europe Therapeutic Radiopharmaceuticals Sales by Country (2023-2028) & (K Units)
Table 69. Europe Therapeutic Radiopharmaceuticals Revenue by Country (2017-2022) & (US$ Million)
Table 70. Europe Therapeutic Radiopharmaceuticals Revenue by Country (2023-2028) & (US$ Million)
Table 71. Asia Pacific Therapeutic Radiopharmaceuticals Sales by Type (2017-2022) & (K Units)
Table 72. Asia Pacific Therapeutic Radiopharmaceuticals Sales by Type (2023-2028) & (K Units)
Table 73. Asia Pacific Therapeutic Radiopharmaceuticals Revenue by Type (2017-2022) & (US$ Million)
Table 74. Asia Pacific Therapeutic Radiopharmaceuticals Revenue by Type (2023-2028) & (US$ Million)
Table 75. Asia Pacific Therapeutic Radiopharmaceuticals Sales by Application (2017-2022) & (K Units)
Table 76. Asia Pacific Therapeutic Radiopharmaceuticals Sales by Application (2023-2028) & (K Units)
Table 77. Asia Pacific Therapeutic Radiopharmaceuticals Revenue by Application (2017-2022) & (US$ Million)
Table 78. Asia Pacific Therapeutic Radiopharmaceuticals Revenue by Application (2023-2028) & (US$ Million)
Table 79. Asia Pacific Therapeutic Radiopharmaceuticals Sales by Region (2017-2022) & (K Units)
Table 80. Asia Pacific Therapeutic Radiopharmaceuticals Sales by Region (2023-2028) & (K Units)
Table 81. Asia Pacific Therapeutic Radiopharmaceuticals Revenue by Region (2017-2022) & (US$ Million)
Table 82. Asia Pacific Therapeutic Radiopharmaceuticals Revenue by Region (2023-2028) & (US$ Million)
Table 83. Latin America Therapeutic Radiopharmaceuticals Sales by Type (2017-2022) & (K Units)
Table 84. Latin America Therapeutic Radiopharmaceuticals Sales by Type (2023-2028) & (K Units)
Table 85. Latin America Therapeutic Radiopharmaceuticals Revenue by Type (2017-2022) & (US$ Million)
Table 86. Latin America Therapeutic Radiopharmaceuticals Revenue by Type (2023-2028) & (US$ Million)
Table 87. Latin America Therapeutic Radiopharmaceuticals Sales by Application (2017-2022) & (K Units)
Table 88. Latin America Therapeutic Radiopharmaceuticals Sales by Application (2023-2028) & (K Units)
Table 89. Latin America Therapeutic Radiopharmaceuticals Revenue by Application (2017-2022) & (US$ Million)
Table 90. Latin America Therapeutic Radiopharmaceuticals Revenue by Application (2023-2028) & (US$ Million)
Table 91. Latin America Therapeutic Radiopharmaceuticals Sales by Country (2017-2022) & (K Units)
Table 92. Latin America Therapeutic Radiopharmaceuticals Sales by Country (2023-2028) & (K Units)
Table 93. Latin America Therapeutic Radiopharmaceuticals Revenue by Country (2017-2022) & (US$ Million)
Table 94. Latin America Therapeutic Radiopharmaceuticals Revenue by Country (2023-2028) & (US$ Million)
Table 95. Middle East and Africa Therapeutic Radiopharmaceuticals Sales by Type (2017-2022) & (K Units)
Table 96. Middle East and Africa Therapeutic Radiopharmaceuticals Sales by Type (2023-2028) & (K Units)
Table 97. Middle East and Africa Therapeutic Radiopharmaceuticals Revenue by Type (2017-2022) & (US$ Million)
Table 98. Middle East and Africa Therapeutic Radiopharmaceuticals Revenue by Type (2023-2028) & (US$ Million)
Table 99. Middle East and Africa Therapeutic Radiopharmaceuticals Sales by Application (2017-2022) & (K Units)
Table 100. Middle East and Africa Therapeutic Radiopharmaceuticals Sales by Application (2023-2028) & (K Units)
Table 101. Middle East and Africa Therapeutic Radiopharmaceuticals Revenue by Application (2017-2022) & (US$ Million)
Table 102. Middle East and Africa Therapeutic Radiopharmaceuticals Revenue by Application (2023-2028) & (US$ Million)
Table 103. Middle East and Africa Therapeutic Radiopharmaceuticals Sales by Country (2017-2022) & (K Units)
Table 104. Middle East and Africa Therapeutic Radiopharmaceuticals Sales by Country (2023-2028) & (K Units)
Table 105. Middle East and Africa Therapeutic Radiopharmaceuticals Revenue by Country (2017-2022) & (US$ Million)
Table 106. Middle East and Africa Therapeutic Radiopharmaceuticals Revenue by Country (2023-2028) & (US$ Million)
Table 107. Bayer Corporation Information
Table 108. Bayer Description and Major Businesses
Table 109. Bayer Therapeutic Radiopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 110. Bayer Therapeutic Radiopharmaceuticals Product Model Numbers, Pictures, Descriptions and Specifications
Table 111. Bayer Recent Developments
Table 112. Novartis Corporation Information
Table 113. Novartis Description and Major Businesses
Table 114. Novartis Therapeutic Radiopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 115. Novartis Therapeutic Radiopharmaceuticals Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. Novartis Recent Developments
Table 117. China Isotope & Radiation Corporation Information
Table 118. China Isotope & Radiation Description and Major Businesses
Table 119. China Isotope & Radiation Therapeutic Radiopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 120. China Isotope & Radiation Therapeutic Radiopharmaceuticals Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. China Isotope & Radiation Recent Developments
Table 122. Dongcheng Corporation Information
Table 123. Dongcheng Description and Major Businesses
Table 124. Dongcheng Therapeutic Radiopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 125. Dongcheng Therapeutic Radiopharmaceuticals Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. Dongcheng Recent Developments
Table 127. Q BioMed Corporation Information
Table 128. Q BioMed Description and Major Businesses
Table 129. Q BioMed Therapeutic Radiopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 130. Q BioMed Therapeutic Radiopharmaceuticals Product Model Numbers, Pictures, Descriptions and Specifications
Table 131. Q BioMed Recent Developments
Table 132. Curium Pharmaceuticals Corporation Information
Table 133. Curium Pharmaceuticals Description and Major Businesses
Table 134. Curium Pharmaceuticals Therapeutic Radiopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 135. Curium Pharmaceuticals Therapeutic Radiopharmaceuticals Product Model Numbers, Pictures, Descriptions and Specifications
Table 136. Curium Pharmaceuticals Recent Developments
Table 137. Jubilant DraxImage Corporation Information
Table 138. Jubilant DraxImage Description and Major Businesses
Table 139. Jubilant DraxImage Therapeutic Radiopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 140. Jubilant DraxImage Therapeutic Radiopharmaceuticals Product Model Numbers, Pictures, Descriptions and Specifications
Table 141. Jubilant DraxImage Recent Developments
Table 142. Lantheus Corporation Information
Table 143. Lantheus Description and Major Businesses
Table 144. Lantheus Therapeutic Radiopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 145. Lantheus Therapeutic Radiopharmaceuticals Product Model Numbers, Pictures, Descriptions and Specifications
Table 146. Lantheus Recent Developments
Table 147. Spectrum Pharmaceuticals Corporation Information
Table 148. Spectrum Pharmaceuticals Description and Major Businesses
Table 149. Spectrum Pharmaceuticals Therapeutic Radiopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 150. Spectrum Pharmaceuticals Therapeutic Radiopharmaceuticals Product Model Numbers, Pictures, Descriptions and Specifications
Table 151. Spectrum Pharmaceuticals Recent Developments
Table 152. Progenics Pharmaceuticals Corporation Information
Table 153. Progenics Pharmaceuticals Description and Major Businesses
Table 154. Progenics Pharmaceuticals Therapeutic Radiopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 155. Progenics Pharmaceuticals Therapeutic Radiopharmaceuticals Product Model Numbers, Pictures, Descriptions and Specifications
Table 156. Progenics Pharmaceuticals Recent Developments
Table 157. International Isotopes Corporation Information
Table 158. International Isotopes Description and Major Businesses
Table 159. International Isotopes Therapeutic Radiopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 160. International Isotopes Therapeutic Radiopharmaceuticals Product Model Numbers, Pictures, Descriptions and Specifications
Table 161. International Isotopes Recent Developments
Table 162. Key Raw Materials Lists
Table 163. Raw Materials Key Suppliers Lists
Table 164. Therapeutic Radiopharmaceuticals Distributors List
Table 165. Therapeutic Radiopharmaceuticals Customers List
Table 166. Therapeutic Radiopharmaceuticals Market Trends
Table 167. Therapeutic Radiopharmaceuticals Market Drivers
Table 168. Therapeutic Radiopharmaceuticals Market Challenges
Table 169. Therapeutic Radiopharmaceuticals Market Restraints
Table 170. Research Programs/Design for This Report
Table 171. Key Data Information from Secondary Sources
Table 172. Key Data Information from Primary Sources
List of Figures
Figure 1. Therapeutic Radiopharmaceuticals Product Picture
Figure 3. Global Therapeutic Radiopharmaceuticals Market Share by Type in 2021 & 2028
Figure 3. Radium-223 Product Picture
Figure 4. Lutetium-177 Product Picture
Figure 5. Iodine-131 Product Picture
Figure 6. Other Product Picture
Figure 7. Global Therapeutic Radiopharmaceuticals Market Share by Application in 2021 & 2028
Figure 8. Thyroid
Figure 9. Bone Metastasis
Figure 10. Lymphoma
Figure 11. Other
Figure 12. Therapeutic Radiopharmaceuticals Report Years Considered
Figure 13. Global Therapeutic Radiopharmaceuticals Sales 2017-2028 (K Units)
Figure 14. Global Therapeutic Radiopharmaceuticals Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 15. Global Therapeutic Radiopharmaceuticals Revenue 2017-2028 (US$ Million)
Figure 16. Global Therapeutic Radiopharmaceuticals Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 17. Global Therapeutic Radiopharmaceuticals Sales Market Share by Region (2017-2022)
Figure 18. Global Therapeutic Radiopharmaceuticals Sales Market Share by Region (2023-2028)
Figure 19. North America Therapeutic Radiopharmaceuticals Sales YoY (2017-2028) & (K Units)
Figure 20. North America Therapeutic Radiopharmaceuticals Revenue YoY (2017-2028) & (US$ Million)
Figure 21. Europe Therapeutic Radiopharmaceuticals Sales YoY (2017-2028) & (K Units)
Figure 22. Europe Therapeutic Radiopharmaceuticals Revenue YoY (2017-2028) & (US$ Million)
Figure 23. Asia-Pacific Therapeutic Radiopharmaceuticals Sales YoY (2017-2028) & (K Units)
Figure 24. Asia-Pacific Therapeutic Radiopharmaceuticals Revenue YoY (2017-2028) & (US$ Million)
Figure 25. Latin America Therapeutic Radiopharmaceuticals Sales YoY (2017-2028) & (K Units)
Figure 26. Latin America Therapeutic Radiopharmaceuticals Revenue YoY (2017-2028) & (US$ Million)
Figure 27. Middle East & Africa Therapeutic Radiopharmaceuticals Sales YoY (2017-2028) & (K Units)
Figure 28. Middle East & Africa Therapeutic Radiopharmaceuticals Revenue YoY (2017-2028) & (US$ Million)
Figure 29. The Therapeutic Radiopharmaceuticals Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 30. The Top 5 and 10 Largest Manufacturers of Therapeutic Radiopharmaceuticals in the World: Market Share by Therapeutic Radiopharmaceuticals Revenue in 2021
Figure 31. Global Therapeutic Radiopharmaceuticals Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 32. Global Therapeutic Radiopharmaceuticals Sales Market Share by Type (2017-2028)
Figure 33. Global Therapeutic Radiopharmaceuticals Revenue Market Share by Type (2017-2028)
Figure 34. Global Therapeutic Radiopharmaceuticals Sales Market Share by Application (2017-2028)
Figure 35. Global Therapeutic Radiopharmaceuticals Revenue Market Share by Application (2017-2028)
Figure 36. North America Therapeutic Radiopharmaceuticals Sales Market Share by Type (2017-2028)
Figure 37. North America Therapeutic Radiopharmaceuticals Revenue Market Share by Type (2017-2028)
Figure 38. North America Therapeutic Radiopharmaceuticals Sales Market Share by Application (2017-2028)
Figure 39. North America Therapeutic Radiopharmaceuticals Revenue Market Share by Application (2017-2028)
Figure 40. North America Therapeutic Radiopharmaceuticals Sales Share by Country (2017-2028)
Figure 41. North America Therapeutic Radiopharmaceuticals Revenue Share by Country (2017-2028)
Figure 42. U.S. Therapeutic Radiopharmaceuticals Revenue (2017-2028) & (US$ Million)
Figure 43. Canada Therapeutic Radiopharmaceuticals Revenue (2017-2028) & (US$ Million)
Figure 44. Europe Therapeutic Radiopharmaceuticals Sales Market Share by Type (2017-2028)
Figure 45. Europe Therapeutic Radiopharmaceuticals Revenue Market Share by Type (2017-2028)
Figure 46. Europe Therapeutic Radiopharmaceuticals Sales Market Share by Application (2017-2028)
Figure 47. Europe Therapeutic Radiopharmaceuticals Revenue Market Share by Application (2017-2028)
Figure 48. Europe Therapeutic Radiopharmaceuticals Sales Share by Country (2017-2028)
Figure 49. Europe Therapeutic Radiopharmaceuticals Revenue Share by Country (2017-2028)
Figure 50. Germany Therapeutic Radiopharmaceuticals Revenue (2017-2028) & (US$ Million)
Figure 51. France Therapeutic Radiopharmaceuticals Revenue (2017-2028) & (US$ Million)
Figure 52. U.K. Therapeutic Radiopharmaceuticals Revenue (2017-2028) & (US$ Million)
Figure 53. Italy Therapeutic Radiopharmaceuticals Revenue (2017-2028) & (US$ Million)
Figure 54. Russia Therapeutic Radiopharmaceuticals Revenue (2017-2028) & (US$ Million)
Figure 55. Asia Pacific Therapeutic Radiopharmaceuticals Sales Market Share by Type (2017-2028)
Figure 56. Asia Pacific Therapeutic Radiopharmaceuticals Revenue Market Share by Type (2017-2028)
Figure 57. Asia Pacific Therapeutic Radiopharmaceuticals Sales Market Share by Application (2017-2028)
Figure 58. Asia Pacific Therapeutic Radiopharmaceuticals Revenue Market Share by Application (2017-2028)
Figure 59. Asia Pacific Therapeutic Radiopharmaceuticals Sales Share by Region (2017-2028)
Figure 60. Asia Pacific Therapeutic Radiopharmaceuticals Revenue Share by Region (2017-2028)
Figure 61. China Therapeutic Radiopharmaceuticals Revenue (2017-2028) & (US$ Million)
Figure 62. Japan Therapeutic Radiopharmaceuticals Revenue (2017-2028) & (US$ Million)
Figure 63. South Korea Therapeutic Radiopharmaceuticals Revenue (2017-2028) & (US$ Million)
Figure 64. India Therapeutic Radiopharmaceuticals Revenue (2017-2028) & (US$ Million)
Figure 65. Australia Therapeutic Radiopharmaceuticals Revenue (2017-2028) & (US$ Million)
Figure 66. Taiwan Therapeutic Radiopharmaceuticals Revenue (2017-2028) & (US$ Million)
Figure 67. Indonesia Therapeutic Radiopharmaceuticals Revenue (2017-2028) & (US$ Million)
Figure 68. Thailand Therapeutic Radiopharmaceuticals Revenue (2017-2028) & (US$ Million)
Figure 69. Malaysia Therapeutic Radiopharmaceuticals Revenue (2017-2028) & (US$ Million)
Figure 70. Philippines Therapeutic Radiopharmaceuticals Revenue (2017-2028) & (US$ Million)
Figure 71. Latin America Therapeutic Radiopharmaceuticals Sales Market Share by Type (2017-2028)
Figure 72. Latin America Therapeutic Radiopharmaceuticals Revenue Market Share by Type (2017-2028)
Figure 73. Latin America Therapeutic Radiopharmaceuticals Sales Market Share by Application (2017-2028)
Figure 74. Latin America Therapeutic Radiopharmaceuticals Revenue Market Share by Application (2017-2028)
Figure 75. Latin America Therapeutic Radiopharmaceuticals Sales Share by Country (2017-2028)
Figure 76. Latin America Therapeutic Radiopharmaceuticals Revenue Share by Country (2017-2028)
Figure 77. Mexico Therapeutic Radiopharmaceuticals Revenue (2017-2028) & (US$ Million)
Figure 78. Brazil Therapeutic Radiopharmaceuticals Revenue (2017-2028) & (US$ Million)
Figure 79. Argentina Therapeutic Radiopharmaceuticals Revenue (2017-2028) & (US$ Million)
Figure 80. Middle East and Africa Therapeutic Radiopharmaceuticals Sales Market Share by Type (2017-2028)
Figure 81. Middle East and Africa Therapeutic Radiopharmaceuticals Revenue Market Share by Type (2017-2028)
Figure 82. Middle East and Africa Therapeutic Radiopharmaceuticals Sales Market Share by Application (2017-2028)
Figure 83. Middle East and Africa Therapeutic Radiopharmaceuticals Revenue Market Share by Application (2017-2028)
Figure 84. Middle East and Africa Therapeutic Radiopharmaceuticals Sales Share by Country (2017-2028)
Figure 85. Middle East and Africa Therapeutic Radiopharmaceuticals Revenue Share by Country (2017-2028)
Figure 86. Turkey Therapeutic Radiopharmaceuticals Revenue (2017-2028) & (US$ Million)
Figure 87. Saudi Arabia Therapeutic Radiopharmaceuticals Revenue (2017-2028) & (US$ Million)
Figure 88. U.A.E Therapeutic Radiopharmaceuticals Revenue (2017-2028) & (US$ Million)
Figure 89. Therapeutic Radiopharmaceuticals Value Chain
Figure 90. Therapeutic Radiopharmaceuticals Production Process
Figure 91. Channels of Distribution
Figure 92. Distributors Profiles
Figure 93. Bottom-up and Top-down Approaches for This Report
Figure 94. Data Triangulation
Figure 95. Key Executives Interviewed
